XML 38 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segment Information (Tables)
 9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,

 
October 1,

 
September 30,

 
October 1,

(In millions)
 
2017

 
2016

 
2017

 
2016

 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
1,382.0

 
$
1,312.3

 
$
4,150.1

 
$
3,897.9

Analytical Instruments
 
1,189.6

 
898.0

 
3,407.4

 
2,451.2

Specialty Diagnostics
 
843.7

 
798.9

 
2,571.9

 
2,504.8

Laboratory Products and Services
 
1,933.0

 
1,674.5

 
5,424.5

 
5,043.0

Eliminations
 
(232.1
)
 
(192.8
)
 
(682.7
)
 
(576.0
)
 
 
 
 
 
 
 
 
 
Consolidated revenues
 
5,116.2

 
4,490.9

 
14,871.2

 
13,320.9

 
 
 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
453.0

 
387.9

 
1,335.0

 
1,128.8

Analytical Instruments
 
256.6

 
190.1

 
681.0

 
446.7

Specialty Diagnostics
 
218.8

 
214.4

 
687.7

 
682.4

Laboratory Products and Services
 
243.4

 
240.1

 
706.3

 
736.8

 
 
 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
1,171.8

 
1,032.5

 
3,410.0

 
2,994.7

 
 
 
 
 
 
 
 
 
Cost of revenues charges
 
(45.1
)
 
(32.4
)
 
(76.7
)
 
(60.4
)
Selling, general and administrative charges, net
 
(36.4
)
 
(62.5
)
 
(74.7
)
 
(95.2
)
Restructuring and other costs, net
 
(49.1
)
 
(54.9
)
 
(95.1
)
 
(140.9
)
Amortization of acquisition-related intangible assets
 
(405.0
)
 
(341.6
)
 
(1,153.4
)
 
(1,001.6
)
 
 
 
 
 
 
 
 
 
Consolidated operating income
 
636.2

 
541.1

 
2,010.1

 
1,696.6

Other expense, net (b)
 
(155.6
)
 
(113.2
)
 
(401.0
)
 
(324.6
)
 
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
480.6

 
$
427.9

 
$
1,609.1

 
$
1,372.0

 
 
 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
31.7

 
$
34.4

 
$
96.9

 
$
109.0

Analytical Instruments
 
17.4

 
11.4

 
51.5

 
30.9

Specialty Diagnostics
 
18.5

 
17.3

 
53.8

 
53.5

Laboratory Products and Services
 
44.2

 
28.3

 
103.9

 
89.2

 
 
 
 
 
 
 
 
 
Consolidated depreciation
 
$
111.8

 
$
91.4

 
$
306.1

 
$
282.6

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,

 
October 1,

 
September 30,

 
October 1,

(In millions)
 
2017

 
2016

 
2017

 
2016

 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
1,382.0

 
$
1,312.3

 
$
4,150.1

 
$
3,897.9

Analytical Instruments
 
1,189.6

 
898.0

 
3,407.4

 
2,451.2

Specialty Diagnostics
 
843.7

 
798.9

 
2,571.9

 
2,504.8

Laboratory Products and Services
 
1,933.0

 
1,674.5

 
5,424.5

 
5,043.0

Eliminations
 
(232.1
)
 
(192.8
)
 
(682.7
)
 
(576.0
)
 
 
 
 
 
 
 
 
 
Consolidated revenues
 
5,116.2

 
4,490.9

 
14,871.2

 
13,320.9

 
 
 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
453.0

 
387.9

 
1,335.0

 
1,128.8

Analytical Instruments
 
256.6

 
190.1

 
681.0

 
446.7

Specialty Diagnostics
 
218.8

 
214.4

 
687.7

 
682.4

Laboratory Products and Services
 
243.4

 
240.1

 
706.3

 
736.8

 
 
 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
1,171.8

 
1,032.5

 
3,410.0

 
2,994.7

 
 
 
 
 
 
 
 
 
Cost of revenues charges
 
(45.1
)
 
(32.4
)
 
(76.7
)
 
(60.4
)
Selling, general and administrative charges, net
 
(36.4
)
 
(62.5
)
 
(74.7
)
 
(95.2
)
Restructuring and other costs, net
 
(49.1
)
 
(54.9
)
 
(95.1
)
 
(140.9
)
Amortization of acquisition-related intangible assets
 
(405.0
)
 
(341.6
)
 
(1,153.4
)
 
(1,001.6
)
 
 
 
 
 
 
 
 
 
Consolidated operating income
 
636.2

 
541.1

 
2,010.1

 
1,696.6

Other expense, net (b)
 
(155.6
)
 
(113.2
)
 
(401.0
)
 
(324.6
)
 
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
480.6

 
$
427.9

 
$
1,609.1

 
$
1,372.0

 
 
 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
31.7

 
$
34.4

 
$
96.9

 
$
109.0

Analytical Instruments
 
17.4

 
11.4

 
51.5

 
30.9

Specialty Diagnostics
 
18.5

 
17.3

 
53.8

 
53.5

Laboratory Products and Services
 
44.2

 
28.3

 
103.9

 
89.2

 
 
 
 
 
 
 
 
 
Consolidated depreciation
 
$
111.8

 
$
91.4

 
$
306.1

 
$
282.6

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.